Cultural variations of coping strategies and quality of life among women with breast cancer undergoing chemotherapy during COVID-19: A two-country cross-sectional study

From 1 October 2026, Triptorelin 3.75mg (Diphereline®) will become available on the PBS for the treatment of a range of women’s health conditions, including breast cancer, endometriosis and uterine fibrosis.

Across August and September, CNSA Communities of Practice continued to bring cancer nurses together to share knowledge, experiences and practical ideas from across the country. Seven CoPs met during this period, covering everything from clinical ethics and survivorship to rare cancers, supportive care and emerging treatments.

Poster 34 | Presenting author: Melanie Regan

Poster 32 | Presenting author: Katie Evans